Wenhui Zhou1, Dapeng Chu1, Wei Sha1, Lei Fu1, Yuan Li2. 1. Medical Center for Human Reproduction, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, People's Republic of China. 2. Medical Center for Human Reproduction, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100020, People's Republic of China. cyliyuan@126.com.
Abstract
PURPOSE: The purpose of this study is to explore whether a low concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF) supplementation in culture medium is beneficial to infertile women aged over 35 years. METHODS: A retrospective cohort study was performed to analyze the embryo quality and pregnancy outcome of 212 controlled ovarian stimulation (COH) cycles with or without GM-CSF addition (n = 117 [GM-CSF, 0.2 ng/mL] vs n = 95 [control]). RESULTS: No significant difference was observed in cleavage rate (96.2 vs 96.5 %), blastocyst formation rate (53.2 vs 54.0 %), good blastocyst rate (26.8 vs 26.8 %), or available embryo rate (54.2 vs 49.7 %) between the GM-CSF group and the control group. However, the average age of the GM-CSF group (38.41 ± 3.13 years) was significantly 1 year older than that of the corresponding control group (37.45 ± 2.74 years) (P < 0.05). GM-CSF addition greatly decreased the occurrence of biochemical pregnancy (55.6 % [control] vs 20.8 % [GM-CSF], P < 0.05). No case of neonatal malformation was observed in the present study. CONCLUSION: Although no benefit of GM-CSF on embryo quality was observed, the addition of this factor significantly decreased the occurrence of chemical pregnancy of women aged over 35 years, indicating the role of GM-CSF in improving implantation competence of embryos derived from elderly infertile women.
PURPOSE: The purpose of this study is to explore whether a low concentration of granulocyte-macrophage colony-stimulating factor (GM-CSF) supplementation in culture medium is beneficial to infertilewomen aged over 35 years. METHODS: A retrospective cohort study was performed to analyze the embryo quality and pregnancy outcome of 212 controlled ovarian stimulation (COH) cycles with or without GM-CSF addition (n = 117 [GM-CSF, 0.2 ng/mL] vs n = 95 [control]). RESULTS: No significant difference was observed in cleavage rate (96.2 vs 96.5 %), blastocyst formation rate (53.2 vs 54.0 %), good blastocyst rate (26.8 vs 26.8 %), or available embryo rate (54.2 vs 49.7 %) between the GM-CSF group and the control group. However, the average age of the GM-CSF group (38.41 ± 3.13 years) was significantly 1 year older than that of the corresponding control group (37.45 ± 2.74 years) (P < 0.05). GM-CSF addition greatly decreased the occurrence of biochemical pregnancy (55.6 % [control] vs 20.8 % [GM-CSF], P < 0.05). No case of neonatal malformation was observed in the present study. CONCLUSION: Although no benefit of GM-CSF on embryo quality was observed, the addition of this factor significantly decreased the occurrence of chemical pregnancy of women aged over 35 years, indicating the role of GM-CSF in improving implantation competence of embryos derived from elderly infertilewomen.
Authors: John C Dumoulin; Jolande A Land; Aafke P Van Montfoort; Ewka C Nelissen; Edith Coonen; Josien G Derhaag; Inge L Schreurs; Gerard A Dunselman; Arnold D Kester; Joep P Geraedts; Johannes L Evers Journal: Hum Reprod Date: 2010-01-18 Impact factor: 6.918
Authors: Ewka C M Nelissen; Aafke P A Van Montfoort; Luc J M Smits; Paul P C A Menheere; Johannes L H Evers; Edith Coonen; Josien G Derhaag; Louis L Peeters; Audrey B Coumans; John C M Dumoulin Journal: Hum Reprod Date: 2013-05-10 Impact factor: 6.918
Authors: R Poverini; R Lisi; F Lisi; V Berlinghieri; W Bielli; P Carfagna; A Costantino; D Iacomino; G Nicodemo Journal: Cell Death Discov Date: 2018-02-20
Authors: Eliab Estrada-Cortés; Elizabeth A Jannaman; Jeremy Block; Thiago F Amaral; Peter J Hansen Journal: J Anim Sci Date: 2021-08-01 Impact factor: 3.338